SCHEDULE OF COMMON STOCK OUTSTANDING (Details) - Common Stock [Member] - USD ($) |
6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Number of Options Outstanding and Vested, Outstanding, Balance | 40,667 | 50,667 | ||||||
Weighted Average Exercise Price, Outstanding, Balance | $ 0.2041 | $ 15.9474 | ||||||
Remaining Contractual Life (Years) | 3 years 5 months 8 days | 2 years 4 months 24 days | ||||||
Aggregated Intrinsic Value, Balance | $ 249,122 | $ 776,864 | ||||||
Number of Options Outstanding and Vested, Issued | 439,996 | [1] | 429,996 | [2] | ||||
Weighted Average Exercise Price, Issued | $ 0.0077 | [1] | $ 0.0077 | [2] | ||||
Number of Options Outstanding and Vested, Outstanding, Balance | 480,663 | 480,664 | ||||||
Weighted average exercise price, outstanding ending | $ 0.0243 | $ 1.6879 | ||||||
Remaining Contractual Life (Years) | 4 years 10 months 17 days | 8 years 1 month 28 days | ||||||
Aggregated Intrinsic Value, Balance | $ 1,804,206 | $ 4,562,782 | ||||||
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|